Hawk70 again I don’t know who this Roch is
Simple so you don’t get confused:
AGN doing phase 2 for Stroke only
NYR doing phase 1 study for stroke and traumatic brain injury. As per company announcements its next quarter and fully funded for it
Both drugs work by inhibiting calcium influx into the brain which calcium is cytotoxic in large quantities. Both drugs are revolutionary and if one succeeds the other is likely to follow.
NYR 6 million market cap
AGN 110 million market cap
I own both but the return of investment for NYR about to dose the first human and the upside for both Traumatic brain injury and Stroke is right now significantly larger. AGN in phase 2 success end of next year will put this at a billion dollar plus market cap as per CEO interviews. The upside for both companies are significant
- Forums
- ASX - By Stock
- AGN Media thread
Hawk70 again I don’t know who this Roch isSimple so you don’t...
-
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
82.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.2M |
Open | High | Low | Value | Volume |
82.0¢ | 83.0¢ | 81.0¢ | $79.25K | 97.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2287 | 82.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
82.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2287 | 0.820 |
2 | 24000 | 0.815 |
1 | 6250 | 0.810 |
1 | 4000 | 0.805 |
1 | 11000 | 0.800 |
Price($) | Vol. | No. |
---|---|---|
0.825 | 5000 | 1 |
0.830 | 9845 | 1 |
0.850 | 9000 | 1 |
0.855 | 10000 | 1 |
0.860 | 5500 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online